Hemodialysis Global Market Report 2026

Hemodialysis is a medical treatment process that involves the cleansing of blood using a dialyzer, commonly referred to as an artificial kidney, and a dialysis machine. This procedure is employed to filter waste and excess fluids from the blood when the kidneys are no longer able to perform this function adequately.

The primary types of hemodialysis include conventional hemodialysis, short daily hemodialysis or daily hemodialysis, and nocturnal hemodialysis. Conventional hemodialysis is typically conducted three times a week, with each session lasting several hours. Various components utilized in hemodialysis include the dialyzer, dialysis solution, tubes, catheter, and other related materials. These components find application across various end-users, including hospitals, specialty clinics, home-care settings, and others.

Tariffs are impacting the hemodialysis market by increasing costs of imported dialysis machines, dialyzers, tubing sets, sensors, and electronic control systems. Healthcare providers in North America and Europe are most affected due to reliance on imported dialysis equipment and consumables, while Asia-Pacific faces pricing pressure on export-oriented manufacturing. These tariffs are increasing treatment costs and capital expenditure for dialysis centers. However, they are also encouraging domestic production of dialysis components, regional manufacturing expansion, and supply chain localization for essential dialysis products.

The hemodialysis market research report is one of a series of new reports from The Business Research Company that provides hemodialysis market statistics, including hemodialysis industry global market size, regional shares, competitors with a hemodialysis market share, detailed hemodialysis market segments, market trends and opportunities, and any further data you may need to thrive in the hemodialysis industry. This hemodialysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemodialysis market size has grown strongly in recent years. It will grow from $95.52 billion in 2025 to $101.58 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing prevalence of chronic kidney disease, expansion of dialysis treatment centers, rising aging population, improved reimbursement coverage for dialysis, technological improvements in dialyzers.

The hemodialysis market size is expected to see strong growth in the next few years. It will grow to $132.17 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing shift toward home-based dialysis care, rising investments in remote dialysis monitoring, growing demand for compact dialysis equipment, expansion of personalized dialysis regimens, continuous innovation in dialysis consumables. Major trends in the forecast period include increasing adoption of home hemodialysis systems, rising demand for advanced dialysis machines, growing integration of digital patient monitoring, expansion of portable dialysis solutions, enhanced focus on patient-centric dialysis care.

The rising incidence of kidney failure is expected to drive the growth of the hemodialysis market in the coming years. Kidney failure is a medical condition characterized by the kidneys' inability to effectively filter waste and excess fluids from the blood. The increase in kidney failure cases is largely attributed to the growing rates of chronic conditions such as diabetes and hypertension, coupled with an aging population and lifestyle factors. Patients with kidney failure rely on hemodialysis to artificially filter and eliminate waste, excess fluids, and toxins from their blood through a machine, compensating for the reduced function of their kidneys. For example, a report published in June 2023 by Nephrology Dialysis Transplantation (NDT), a UK-based journal, projected that the number of individuals with Chronic Kidney Disease (CKD) in the UK will increase by 4% between 2022 and 2032, rising from 8.27 million to 8.61 million. Thus, the growing prevalence of kidney failure is set to boost the hemodialysis market.

Major companies in the hemodialysis market are increasingly focusing on developing innovative solutions, such as cloud-enabled machines, to remotely monitor patient data, optimize treatment, and improve outcomes. Cloud-enabled machines are internet-connected devices that securely store, process, and share data on cloud servers, enabling remote monitoring, analysis, and management. For example, in June 2025, Renalyx Health Systems Pvt. Ltd., an India-based technology innovation company, launched India's first fully indigenous AI-based smart hemodialysis machine, RENALYX-RxT 21. The system integrates nephrology information systems on the cloud, employs AI-driven smart algorithms, provides real-time remote monitoring and alerts via telemetry, and supports Electronic Medical Records (EMR) integration, allowing doctors to oversee patient care remotely. It also features advanced image processing and Internet of Medical Things (IoMT) capabilities for continuous performance monitoring, aiming to make dialysis safer, more accessible, and affordable, particularly for patients in semi-urban and rural areas.

In July 2023, Rockwell Medical Inc., a US-based manufacturer of hemodialysis concentrates and related products, acquired the hemodialysis concentrates business of Evoqua Water Technologies for $11 million in upfront cash, with up to $5 million in milestone payments. Through this acquisition, Rockwell Medical aims to become a leading supplier of hemodialysis concentrates in the United States by expanding its geographic reach, customer base, and product portfolio while lowering manufacturing costs and increasing production capacity to support long-term growth and profitability. The transaction includes Evoqua's customer contracts, intellectual property, FDA 510(k) clearances, and manufacturing assets for liquid and powder bicarbonate and acid concentrates used in hemodialysis. The acquisition is expected to expand Rockwell's geographic footprint, add capacity, and make the concentrates business immediately accretive to revenue and profitability. Evoqua Water Technologies Ltd., based in the US, provides water and wastewater treatment solutions for industrial, municipal, and recreational customers.

Major companies operating in the hemodialysis market are Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Asahi Kasei Corporation, Nikkiso Co. Ltd., Toray Medical Co. Ltd., DaVita Inc., Diaverum AB, Outset Medical Inc., Quanta Dialysis Technologies Ltd., Rockwell Medical Inc., JMS Co. Ltd., Kawasumi Laboratories Inc., Terumo Corporation, Poly Medicure Ltd., Renax Biomedical Tech. Co. Ltd., Allmed Medical Care Corporation, Hemoclean Co. Ltd., Medcomp Holdings Inc.

North America was the largest region in the hemodialysis market in 2025. Asia-Pacific is expected to be the fastest growing region in the global hemodialysis market report during the forecast period. The regions covered in the hemodialysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemodialysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hemodialysis market includes revenues earned by entities by in-center hemodialysis and peritoneal dialysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemodialysis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses hemodialysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemodialysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemodialysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Conventional Hemodialysis; Short Daily Hemodialysis Or Daily Hemodialysis; Nocturnal Hemodialysis
• 2) By Component: Dialyzer; Dialysis Solution; Tubes; Catheter
• 3) By End User: Hospitals; Specialty Clinics; Home-Care Settings
• Subsegments:
• 1) By Conventional Hemodialysis: In-Center Hemodialysis; Home Hemodialysis
• 2) By Short Daily Hemodialysis Or Daily Hemodialysis: Home-Based Short Daily Hemodialysis; In-Center Short Daily Hemodialysis
• 3) By Nocturnal Hemodialysis: Home Nocturnal Hemodialysis; In-Center Nocturnal Hemodialysis
• Companies Mentioned: Fresenius Medical Care AG & Co. KGaA; Baxter International Inc.; B. Braun Melsungen AG; Nipro Corporation; Asahi Kasei Corporation; Nikkiso Co. Ltd.; Toray Medical Co. Ltd.; DaVita Inc.; Diaverum AB; Outset Medical Inc.; Quanta Dialysis Technologies Ltd.; Rockwell Medical Inc.; JMS Co. Ltd.; Kawasumi Laboratories Inc.; Terumo Corporation; Poly Medicure Ltd.; Renax Biomedical Tech. Co. Ltd.; Allmed Medical Care Corporation; Hemoclean Co. Ltd.; Medcomp Holdings Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.